awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40166955-F4F3213C-1BFB-4FC3-8F1B-3AF1114EAE1E
Q40166955-F4F3213C-1BFB-4FC3-8F1B-3AF1114EAE1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40166955-F4F3213C-1BFB-4FC3-8F1B-3AF1114EAE1E
Time lag between the initiation of adalimumab after methotrexate correlates with the efficacy of adalimumab in rheumatoid arthritis patients.
P2860
Q40166955-F4F3213C-1BFB-4FC3-8F1B-3AF1114EAE1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40166955-F4F3213C-1BFB-4FC3-8F1B-3AF1114EAE1E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ddb4e5f8d8e195f2250d0e68df4a2199bc829f61
P2860
Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study.